시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
근위축성측색경화증 치료 시장 규모, 점유율, 성장 분석 : 치료법별, 유형별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Amyotrophic Lateral Sclerosis Treatment Market Size, Share, Growth Analysis, By Treatment (Medication, Stem Cell Therapy), By Type (Sporadic ALS, Familial ALS), By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드 : 1646224
리서치사 : SkyQuest
발행일 : 2025년 01월
페이지 정보 : 영문 242 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,692,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,998,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,304,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

근위축성측색경화증 치료제 시장 규모는 2023년 7억 1,145만 달러로 평가되며, 예측 기간(2025-2032년) 동안 연평균 5.7%로 성장하여 2024년 7억 5,200만 달러에서 2032년 11억 7,171만 달러로 확대될 것으로 예상됩니다.

근위축성측색경화증(ALS)은 루게릭병으로도 알려져 있으며, 중추신경계의 신경세포 손상으로 인해 의지근육의 조절에 영향을 미치는 진행성 신경퇴행성 질환입니다. ALS의 약 90-95%는 산발성이며, 나머지는 가족성 ALS(FALS)로 주로 C9ORF72 유전자의 돌연변이 등 유전적 요인이 큰 질환입니다. 현재 ALS를 완치시킬 수 있는 치료법은 확립되어 있지 않지만, 약물요법이나 줄기세포 치료와 같은 첨단 치료를 통한 증상 관리가 중요하며, 이는 전 세계 ALS 치료 시장의 성장을 촉진할 것으로 기대되고 있습니다. 이 과제를 해결하기 위해서는 지속적인 연구와 기술 혁신이 필수적입니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

근위축성측색경화증 치료 시장 규모 : 치료법별

근위축성측색경화증 치료 시장 규모 : 유형별

근위축성측색경화증 치료 시장 규모 : 유통 채널별

근위축성측색경화증 치료 시장 규모

경쟁 정보

주요 기업 개요

결론과 추천사항

ksm
영문 목차

영문목차

Amyotrophic Lateral Sclerosis Treatment Market size was valued at USD 711.45 million in 2023 and is poised to grow from USD 752.0 million in 2024 to USD 1171.71 million by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder affecting voluntary muscle control due to nerve cell damage in the central nervous system. Symptoms include muscle twitching, stiffness, and weakness, leading to the loss of essential functions like swallowing, speaking, and mobility. Approximately 90-95% of ALS cases are sporadic, while familial ALS (FALS) accounts for the remainder, with significant genetic components, primarily the C9ORF72 gene mutation. While there is currently no cure for ALS, symptom management through medications and advanced therapies like stem cell treatments is critical and expected to fuel the growth of the global ALS treatment market. Continued research and innovation are essential in addressing this challenging condition.

Top-down and bottom-up approaches were used to estimate and validate the size of the Amyotrophic Lateral Sclerosis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Amyotrophic Lateral Sclerosis Treatment Market Segments Analysis

Global Amyotrophic Lateral Sclerosis Treatment Market is segmented by Treatment, Type, Distribution Channel and region. Based on Treatment, the market is segmented into Medication, Stem Cell Therapy, Physical Therapy and Speech Therapy. Based on Type, the market is segmented into Sporadic ALS and Familial ALS. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Amyotrophic Lateral Sclerosis Treatment Market

The growth of the Amyotrophic Lateral Sclerosis (ALS) treatment market is anticipated to be significantly influenced by the increasing prevalence of the disease. Data from the Centers for Disease Control and Prevention (CDC) indicated that in 2016, approximately 14,500 to 15,000 individuals in the United States were living with ALS, with around 5,000 new diagnoses occurring each year. Furthermore, globally, ALS affects about 2 to 5 individuals per 100,000. The rise in sedentary lifestyles and a growing elderly population also contribute to the heightened demand for both targeted and symptomatic treatments, which will likely stimulate the ALS treatment market in the coming years.

Restraints in the Amyotrophic Lateral Sclerosis Treatment Market

The amyotrophic lateral sclerosis (ALS) treatment market faces several significant restraints that are likely to hinder its growth during the forecast period. The high cost of treatment is a primary concern, as ALS is a rare condition, leading to exorbitant expenses that can reach approximately $200,000 annually, including medication like Edaravone, which alone costs around $145,000. Additionally, there is a general lack of awareness regarding ALS, which further limits patient access to treatment options. Moreover, the uncertainty surrounding the effectiveness of these costly treatments, associated with low survival rates, presents a substantial challenge for market expansion and patient confidence.

Market Trends of the Amyotrophic Lateral Sclerosis Treatment Market

The amyotrophic lateral sclerosis (ALS) treatment market is witnessing significant growth driven by the increasing prevalence of neurodegenerative disorders amidst busy lifestyles and rising incidences of ALS. The expanding geriatric population, particularly vulnerable to such conditions, is further propelling market expansion. Additionally, various NGOs and private organizations are actively promoting awareness campaigns focused on ALS diagnosis and treatment, fostering a more informed patient base and enhancing market outlook. The emergence of targeted symptomatic treatments aimed at alleviating ALS symptoms is also contributing to market growth, reflecting a robust trend towards more personalized and effective therapeutic solutions in the ALS landscape.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Amyotrophic Lateral Sclerosis Treatment Market Size by Treatment & CAGR (2025-2032)

Global Amyotrophic Lateral Sclerosis Treatment Market Size by Type & CAGR (2025-2032)

Global Amyotrophic Lateral Sclerosis Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Global Amyotrophic Lateral Sclerosis Treatment Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기